- WBSCR22 confers oxaliplatin resistance in human colorectal cancerYan Dongmei; Tu Linglan; Yuan Haining; Fang Jianfei; Cheng Liyan; Zheng Xiaoliang; Wang XiaojuScientific Reports, 2017, 7: 15443.
- Upregulation of CYP2S1 by oxaliplatin is associated with p53 status in colorectal cancer cell linesYang Chao; Zhou Qian; Li Minle; Tong Xuemei; Sun Jiayi; Qing Yin; Sun Liya; Yang Xuhan; Hu Xiaowen; Jiang Jie; Yan Xiaomei; He Lin; Wan ChunlingScientific Reports, 2016, 6: 33078.
- Growth Inhibition of Human Colon Cancer Cell Line HCT116 by Bis[2-(acylamino)phenyl] Disulfide and Its Action MechanismSatoshi, Yamakawa; Aya, Demizu; Yasuyuki, Kawaratani; Yasuo, Nagaoka; Yuji, Terada; Sakiko, Maruyama; Shinichi, UesatoBiological and Pharmaceutical Bulletin, 2008, 31(5): 916-920.被引 7
会议论文
EXOGENOUS WP53 REVERSES 5-FU RESISTANCE IN COLORECTAL CANCER BY INHIBITING THE CELL MEMBRANE EFFLUX PUMP AND THE BIOSYNTHESIS AND DETOXIFICATION OF GSH IN VIVO
34阅读
